Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ann Lovell"'
Autor:
Meridith Ann Lovell-Johnston
Publikováno v:
Language and Literacy: A Canadian Educational e-journal, Vol 21, Iss 3, Pp 79-111 (2019)
This article explores the concept of lesson interactivity within six primary and elementary teachers’ use of whole-class and personal digital devices over multiple lessons including Interactive Whiteboards, data projectors, laptop computers, and ot
Externí odkaz:
https://doaj.org/article/e3f9116a28a647b9ae9f893d3865ff17
Autor:
Jennifer E. Fung, Caitlin D. Annable, Meridith Ann Lovell-Johnston, Robert D. Williamson, Denyse V. Hayward, Linda M. Phillips
Publikováno v:
Early Childhood Education Journal. 45:809-820
Current phonological awareness assessment procedures consider only the total score a child achieves. Such an approach may result in children who achieve the same total score receiving the same instruction even though the configuration of their errors
Autor:
Anshuman Panda, Janice M. Mehnert, Howard L. Kaufman, Ann Lovell, Eileen White, Kim M. Hirshfield, Mark N. Stein, Gyan Bhanot, Siraj M. Ali, Katherine Lane, Hua Zhong, Shridar Ganesan, Dean Pavlick, Levi Sokol, Lorna Rodriguez-Rodriquez, Jonathan D. Cheng, Jeffrey S. Ross, Sherri Damare, Robert S. DiPaola
Publikováno v:
The Journal of clinical investigation. 126(6)
Antibodies that target the immune checkpoint receptor programmed cell death protein 1 (PD-1) have resulted in prolonged and beneficial responses toward a variety of human cancers. However, anti-PD-1 therapy in some patients provides no benefit and/or
Autor:
Levi Sokol, Anshuman Panda, Siraj M. Ali, Kim M. Hirshfield, Katherine Stiles, Sherri Damare, Howard L. Kaufman, Janice M. Mehnert, Mark N. Stein, Hua Zhong, Dean Pavlick, Robert S. DiPaola, J.S. Ross, Eileen White, Ann Lovell, Lorna Rodriguez-Rodriguez, Jonathan D. Cheng, Gyan Bhanot, Shridar Ganesan
Publikováno v:
Molecular Cancer Therapeutics. 14:PR05-PR05
Genomic assessment of exceptional responders is a promising approach to identify predictors of response to antibody therapy directed against the immune checkpoint programmed death 1 (PD-1) receptor, which has been shown to yield prolonged and deep re